EUVIMEDEUVIMED entdecken
Crossref

Improving CVD risk assessment with eGFR

Sue Lyon

Future Prescriber · 2006

DOI: 10.1002/fps.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Prescriber, 2006. Verfasst von Sue Lyon.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A quiet revolution is taking place within the NHS as laboratories grad‐ually switch from serum creatinine to estimated glomerular filtration rate (eGFR) as the prime measure of renal function. This change follows recommendations in the National Service Framework for Renal Services,1 but the move will have an impact far beyond the renal com‐munity, affecting health profess‐ionals and patients throughout primary and secondary care. Copyright © 2006 John Wiley & Sons, Ltd.

Zitieren

APA

Lyon, S. (2006). Improving CVD risk assessment with eGFR. Future Prescriber. https://doi.org/10.1002/fps.22

Vancouver

Lyon S. Improving CVD risk assessment with eGFR. Future Prescriber. 2006. doi:10.1002/fps.22

BibTeX
@article{Lyon2006,
  author = {Lyon, Sue},
  title = {Improving CVD risk assessment with eGFR},
  journal = {Future Prescriber},
  year = {2006},
  doi = {10.1002/fps.22}
}
Kostenlos starten →